tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DYN Stock Latest News

Dyne announces MHLW in Japan granted ODD for zeleciment basivarsen
The FlyDyne announces MHLW in Japan granted ODD for zeleciment basivarsen
16d ago
DYN
Dyne Therapeutics Highlights Pipeline and Cash at JPM Conference
PremiumCompany Announcements
Dyne Therapeutics Highlights Pipeline and Cash at JPM Conference
24d ago
8K
DYN
Dyne Therapeutics Appoints Vikram Karnani to Board
PremiumCompany Announcements
Dyne Therapeutics Appoints Vikram Karnani to Board
1M ago
8K
DYN
Dyne Therapeutics appoints Vikram Karnani to board of directors
PremiumThe Fly
Dyne Therapeutics appoints Vikram Karnani to board of directors
1M ago
DYN
COLL
Dyne Therapeutics price target lowered to $36 from $38 at Evercore ISI
PremiumThe Fly
Dyne Therapeutics price target lowered to $36 from $38 at Evercore ISI
2M ago
DYN
Dyne Therapeutics price target raised to $39 from $36 at Stifel
PremiumThe FlyDyne Therapeutics price target raised to $39 from $36 at Stifel
2M ago
DYN
Dyne Therapeutics Announces Upsized Public Offering
Premium
Company Announcements
Dyne Therapeutics Announces Upsized Public Offering
2M ago
8K
DYN
Amazon initiated, GE Vernova upgraded: Wall Street’s top analyst calls
Premium
The Fly
Amazon initiated, GE Vernova upgraded: Wall Street’s top analyst calls
2M ago
M
NE
Oppenheimer upgrades Dyne Therapeutics to Outperform, raises target to $40
PremiumThe Fly
Oppenheimer upgrades Dyne Therapeutics to Outperform, raises target to $40
2M ago
DYN
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
PremiumThe Fly
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
2M ago
DYN
Dyne Therapeutics 18.98M share Secondary priced at $18.44
PremiumThe Fly
Dyne Therapeutics 18.98M share Secondary priced at $18.44
2M ago
DYN
Midday Fly By: Nvidia can ship H200s to China, Campbell’s reports Q1 beat
PremiumThe Fly
Midday Fly By: Nvidia can ship H200s to China, Campbell’s reports Q1 beat
2M ago
C
F
Dyne Therapeutics falls -13.7%
PremiumThe FlyDyne Therapeutics falls -13.7%
2M ago
DYN
Dyne Therapeutics falls -13.7%
Premium
The Fly
Dyne Therapeutics falls -13.7%
2M ago
DYN
Dyne Therapeutics price target raised to $50 from $46 at Morgan Stanley
Premium
The Fly
Dyne Therapeutics price target raised to $50 from $46 at Morgan Stanley
2M ago
DYN
Dyne Therapeutics price target raised to $23 from $21 at Bernstein
PremiumThe Fly
Dyne Therapeutics price target raised to $23 from $21 at Bernstein
2M ago
DYN
Dyne Therapeutics Amends Loan Agreement for $50 Million
PremiumCompany Announcements
Dyne Therapeutics Amends Loan Agreement for $50 Million
2M ago
8K
DYN
Dyne Therapeutics offers to sell $300M in common stock
PremiumThe Fly
Dyne Therapeutics offers to sell $300M in common stock
2M ago
DYN
Dyne Therapeutics price target raised to $60 from $46 at H.C. Wainwright
PremiumThe Fly
Dyne Therapeutics price target raised to $60 from $46 at H.C. Wainwright
2M ago
DYN
Dyne Therapeutics Reports Positive Phase 1/2 Trial Results
PremiumCompany AnnouncementsDyne Therapeutics Reports Positive Phase 1/2 Trial Results
2M ago
8K
DYN
Dyne Therapeutics reports ‘positive’ results from Phase 1/2 DELIVER trial
Premium
The Fly
Dyne Therapeutics reports ‘positive’ results from Phase 1/2 DELIVER trial
2M ago
DYN
Dyne Therapeutics price target raised to $21 from $12 at Bernstein
Premium
The Fly
Dyne Therapeutics price target raised to $21 from $12 at Bernstein
2M ago
DYN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >